Agilent Technologies is partnering with Veeda Lifesciences to launch a joint Center of Excellence in Bengaluru focused on regulatory-aligned analytical and bioanalytical workflows. The hub aims to produce consistent, inspection-ready data across early development, clinical and manufacturing stages, with special emphasis on GLP-1 peptides where sensitivity, throughput and data integrity are crucial. The collaboration combines Agilent mass spectrometry with Veeda proteomics and impurity analysis capabilities.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
